Three groups investigated the action of IL-18 in rodents following administration of KA, an agonist of the kainate receptors inducing seizure, cerebellar ataxia and exitotoxic mediated neuronal loss [53,60,150]. The gene discussed is IL18; the disease is aceruloplasminemia.